Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Contract Services in 2012

February 1, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Some recent private-equity buyouts of CROs show both the upside and downside for investors.

Q&A with Gilles Cottier, SAFC

January 2, 2012
Pharmaceutical Technology

A Q&A with Gilles Cottier, president of SAFC, on recent industry trends.

Global Healthcare on the Ground: Brazil's Development Bank Leader Discusses the Country's Pharma Future

January 2, 2012

Pharmaceutical Technology

As part of the BRIC bloc with Russia, India, and China, Brazil is one of the world's leading emerging economies and is also considered by IMS Health to be one of seven pharmerging nations, which also include Mexico, Turkey, and South Korea.

Contract Services in 2012

January 2, 2012

Pharmaceutical Technology

Some recent private-equity buyouts of CROs show both the upside and downside for investors.

Report from Europe

January 2, 2012

Pharmaceutical Technology

The European Union market takes steps toward continuous processing and modular facilities.

Budget Crunch, Political Battles Shape Policy Agenda for Year

January 2, 2012

Pharmaceutical Technology

Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.

Contract API Manufacturing: The Year in Review

December 2, 2011

Pharmaceutical Technology

Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals.

Troublesome Signs for Bio/Pharmaceutical R&D

December 2, 2011

Pharmaceutical Technology

A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.

FDA Revamps to Meet New Challenges

December 2, 2011

Pharmaceutical Technology

Added responsibilities and outside concerns prompt overhaul of agency's structure.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here